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Introduction
Although human exposure to phenols (or 
their precursors) and parabens is ubiquitous 
in western industrialized countries, little is 
known about the patterns and predictors of 
exposure to these compounds in Asia or about 
their changes over time. One phenol that has 
received particular attention is bisphenol A 
(BPA), used to manufacture resins and poly-
mers found in container linings and dental 
sealants. Other commonly used phenols 
include benzophenone-3, used in sunscreen; 
triclosan, a microbicide used in many house-
hold and personal care products; and parabens, 
used as preservatives in many personal care 
products. Of interest is 2,5-dichloro phenol, a 
metabolite of 1,4-dichlorobenzene, which is 
used in mothballs and room deodorizers.
These phenols are of interest because of 
hormonal and other biological effects observed 
in vitro and in vivo. Effects include weak-to-
moderate estrogenicity and anti androgenicity 
in vitro (Fang et al. 2000), which may disrupt 
the endocrine system in humans, and adverse 
reproductive outcomes, including low birth 
weight and altered reproductive endocrine 
parameters (Savabieasfahani et al. 2006), car-
cinogenicity (National Toxicology Program 
2011), and hematological abnormalities (Aiso 
et al. 2005) in animal models. Determining 
whether these chemicals cause these or other 
adverse health effects in humans at typical 
exposure levels is important.
These phenols pose a challenge for 
exposure assessment in epidemiologic studies 
because they are rapidly eliminated from 
the body, with half-lives of hours [Centers 
for Disease Control and Prevention (CDC) 
2009]. This is of particular concern for pro-
spective epidemiologic studies of diseases with 
long latency, such as cancer, where estimates 
of exposure dating back years to decades may 
be important and where often only a single 
pre diagnostic urine sample is available. Any 
temporal variability in exposure would be 
influenced by behavioral changes (in the use 
of, or exposure to, products) and by secular 
changes in the composition or selection of 
products available on the market, which could 
affect the reliable estimation of individuals’ 
absolute or relative exposures.
Several studies that examined variability 
in urinary concentrations over weeks to 
months reported generally low reproduci-
bility for BPA (Braun et al. 2011, 2012; 
Mahalingaiah et al. 2008; Nepomnaschy 
et al. 2009; Teitelbaum et al. 2008) and fair 
reproducibility for other phenols and para-
bens (Meeker et al. 2011; Smith et al. 2012; 
Teitelbaum et al. 2008) among U.S. children 
and adults. However, the temporal variability 
Address correspondence to L.S. Engel, Department 
of Epidemiology, University of North Carolina at 
Chapel Hill, CB #7435, Chapel Hill, NC 27599-
7435 USA. Telephone: (919) 962-2756. E-mail: 
Larry.Engel@unc.edu
Current address for W.-H.C.: Department of 
Epidemiology, University of Texas MD Anderson 
Cancer Center, Houston, Texas, USA
Supplemental Material is available online (http://
dx.doi.org/10.1289/ehp.1306830).
We gratefully acknowledge X. Ye, X. Zhou, 
J. Kramer, and T. Jia [Centers for Disease Control and 
Prevention (CDC)] for measuring urinary phenol con-
centrations, and R. Vermeulen (Utrecht University, 
the Netherlands) for providing statistical advice.
The urine sample preparation was performed at 
Survey and Biospecimen Shared Resource, which is 
partially supported by the Vanderbilt-Ingram Cancer 
Center (P30 CA068485). 
The findings and conclusions in this report are 
those of the authors and do not necessarily represent 
the official position of the CDC.
The authors declare they have no actual or potential 
competing financial interests.
Received: 21 March 2013; Accepted: 20 March 
2014; Advance Publication: 21 March 2014; Final 
Publication: 1 July 2014.
Predictors and Variability of Repeat Measurements of Urinary Phenols and 
Parabens in a Cohort of Shanghai Women and Men
Lawrence S. Engel,1 Jessie P. Buckley,1 Gong Yang,2 Linda M. Liao,3 Jaya Satagopan,4 Antonia M. Calafat,5 
Charles E. Matthews,3 Qiuyin Cai,2 Bu-Tian Ji,3 Hui Cai,2 Stephanie M. Engel,1 Mary S. Wolff,6 Nathaniel Rothman,3 
Wei Zheng,2 Yong-Bing Xiang,7 Xiao-Ou Shu,2 Yu-Tang Gao,7 and Wong-Ho Chow3
1Department of Epidemiology, UNC Gillings School of Global Public Health, Chapel Hill, North Carolina, USA; 2Department of Medicine, 
Division of Epidemiology, Vanderbilt University School of Medicine, Nashville, Tennessee, USA; 3Division of Cancer Epidemiology and 
Genetics, National Cancer Institute, National Institutes of Health, U.S. Department of Health and Human Services, Bethesda, Maryland, 
USA; 4Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, New York, USA; 5Division 
of Laboratory Sciences, National Center for Environmental Health, Centers for Disease Control and Prevention, Atlanta, Georgia, USA; 
6Department of Community and Preventive Medicine, Mount Sinai School of Medicine, New York, New York, USA; 7Shanghai Cancer 
Registry, Shanghai Cancer Institute, Shanghai, China
Background: Exposure to certain phenols is ubiquitous because of their use in many consumer 
and personal care products. However, predictors of exposure have not been well characterized in 
most populations.
oBjectives: We sought to identify predictors of exposure and to assess the reproducibility of 
phenol concentrations across serial spot urine samples among Chinese adults.
Methods: We measured 2,4-dichloro phenol, 2,5-dichloro phenol, butyl paraben, methyl paraben, 
propyl paraben, benzophenone-3, bisphenol A, and triclosan in urine collected during 1997–2006 
from 50 participants of the Shanghai Women’s Health Study cohort and during 2002–2006 from 
50 participants of the Shanghai Men’s Health Study cohort. We investigated predictors of concentra-
tions using the Satterthwaite t-test, and assessed reproducibility among serial samples using intraclass 
correlation coefficients (ICCs) and Spearman correlation coefficients (SCCs).
results: Creatinine-corrected phenol concentrations were generally higher among women than 
men. Participants who had taken medicine within the previous 24 hr had higher concentra-
tions of propyl paraben. Cigarette smoking was associated with lower concentrations of propyl 
and methyl parabens among men. Bottled water consumption was associated with higher 
bisphenol A, 2,4-dichloro phenol, and 2,5-dichloro phenol concentrations among women. Among 
men, reproducibility across serial samples was moderate for 2,4-dichloro phenol and 2,5-dichloro-
phenol (ICC = 0.54–0.60, SCC = 0.43–0.56), but lower for other analytes (ICC = 0.20–0.29). 
Reproducibility among women was low (ICC = 0.13–0.39), but increased when restricted to 
morning- only urine samples.
conclusions: Among these 100 Shanghai residents, urinary phenol concentrations varied by sex, 
smoking, and consumption of bottled water. Our results suggest that a single urine sample may 
be adequate for ranking exposure to the precursors of 2,4-dichloro phenol and 2,5-dichloro phenol 
among men and, under certain circumstances, among women.
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of urinary concentrations of these chemicals 
either among Asians or over years has not 
previously been described. The aims of the 
present study were to identify predictors of 
exposure to selected phenols and to deter-
mine the reproducibility of phenol concentra-
tions across serial urine samples collected over 
 several years among urban Chinese adults.
Methods
Study population. The Shanghai Women’s 
Health Study (SWHS) and Shanghai Men’s 
Health Study (SMHS) are population-
based, prospective/cohorts of 75,000 women 
(40–70 years of age at baseline) and > 61,000 
men (40–75 years of age at baseline) living 
in urban Shanghai (Cai et al. 2007; Zheng 
et al. 2005). Recruitment occurred during 
1997–2000 for the SWHS and 2002–2006 
for the SMHS. In both studies, eligible partic-
ipants were identified from a roster of all com-
munity residents and all provided informed 
consent; participation rates were 92% in the 
SWHS and 74% in the SMHS. A physical 
activity substudy was begun in 2005 in a ran-
dom sample of SWHS and SMHS partici-
pants; of 1,101 people contacted, 619 (56%) 
agreed to participate (Peters et al. 2010). The 
present analysis included 50 women and 50 
men randomly sampled across strata of age 
and year of baseline urine collection from par-
ticipants in this physical activity substudy. The 
study protocol was approved by institutional 
review boards of the participating institutions. 
The involvement of the CDC laboratory was 
determined not to constitute engagement in 
human subject research.
Questionnaires. During the initial con-
tact at cohort enrollment, SWHS participants 
were given a self-administered questionnaire 
that elicited information on demographics, 
lifestyle, medical history, residence, and occu-
pation. SWHS participants then completed 
an in-person, in-home interview focused on 
diet, reproductive history, physical activity, 
and water consumption either at the initial 
contact or within 2–3 days of initial contact. 
SMHS participants similarly completed in-
person interviews on sociodemographic, life-
style, physical activity, diet, and chronic health 
conditions. Brief interviews at the time of each 
urine sample collection elicited information 
about recent diet and smoking; information 
about medication use within the previous 
24 hr was obtained at the first (baseline) col-
lection. Weight was measured at baseline and 
approximately midway between collection of 
the second and third urine samples.
Urine samples. Spot urine samples were 
collected from 65,754 (88%) SWHS and 
54,668 (89%) SMHS cohort members at the 
baseline interview. Baseline urine samples in 
the present study were collected primarily 
in 1998–1999 for the women (92%) and in 
2003–2004 for the men (100%). A second 
and third spot urine sample was collected 
from physical activity substudy participants 
during two additional home interviews; 535 
(86%) of these participants provided biologi-
cal samples, and 516 (96%) of those providing 
biological samples did so at both interviews. 
Demographic, anthropometric, and lifestyle 
characteristics of cohort members who par-
ticipated in the substudy and provided bio-
logical samples were similar to those of the full 
cohorts, suggesting that selection bias related 
to participating and providing urine samples 
was unlikely. The second sample was collected 
in 2006, an average of 6.7 years and 2.2 years 
after the baseline sample, for women and men, 
respectively. The third sample was collected 
approximately 9 months after the second. 
Urine was collected into steri lized 100 mL 
polypropylene cups containing 125 mg ascor-
bic acid, kept cold with ice packs (0–4°C) 
until processing within 6 hr of collection, and 
then stored at –70 to –80°C. Approximately 
33% of the baseline urine samples was col-
lected in the morning, with the rest collected 
in the afternoon or evening (Table 1). Almost 








Age at enrollment (years)
40–49 40 (40) 27 (54) 13 (26)
50–59 33 (33) 13 (26) 20 (40)
60–72 27 (27) 10 (20) 17 (34)
Highest educational level attained
Elementary school or no formal education 16 (16) 11 (22) 5 (10)
Middle school 38 (38) 19 (38) 19 (38)
High school 30 (30) 13 (26) 17 (34)
≥ Technical school/college 16 (16) 7 (14) 9 (18)
BMI (kg/m2)
< 20 6 (6) 4 (8) 2 (4)
20–24.9 55 (55) 25 (50) 30 (60)
25–29.9 34 (34) 17 (34) 17 (34)






Current 33 (33) 2 (4) 31 (62)
Former 4 (4) 0 (0) 4 (8)
Never 63 (63) 48 (96) 15 (30)
No. of cigarettes smoked/day (among current smokers)
1–6 3 (9) 2 (100) 1 (3)
7–12 11 (33) 0 (0) 11 (35)
≥ 13 19 (58) 0 (0) 19 (61)
Family income in previous yeara
Low 65 (65) 30 (60) 35 (70)
High 35 (35) 20 (40) 15 (30)
Usual source of drinking water
Tap water only 33 (66)
Tap water and bottled water 17 (34)
Any medicine taken within previous 24 hr at baseline
Yes 59 (59) 28 (56) 31 (62)
No 41 (41) 22 (44) 19 (38)
Time of day of collection for baseline urine sample (hours)
0700–0859 4 (4) 3 (6) 1 (2)
0900–1159 29 (29) 12 (24) 17 (34)
1200–1459 12 (12) 6 (12) 6 (12)
1500–1959 55 (55) 29 (58) 26 (52)
Time of day of collection for second urine sample
0700–0859 71 (71) 38 (76) 33 (66)
0900–1159 23 (23) 8 (16) 15 (30)
1200–1459 4 (4) 2 (4) 2 (4)
1500–1959 2 (2) 2 (4) 0 (0)
Time of day of collection for third urine sample
0700–0859 66 (66) 32 (64) 34 (68)
0900–1159 31 (31) 17 (34) 14 (28)
1200–1459 2 (2) 0 (0) 2 (4)
1500–1959 1 (1) 1 (2) 0 (0)
Values shown are n (%).
a“Low” and “high” annual income defined using cut points of 20,000 yuan for women and 12,000 yuan for men, which 
represent the approximate medians reported by each sex.
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all of the second and third urine samples 
(94% and 97%, respectively) were collected in 
the morning.
Laboratory analyses. For each participant, 
one 750-μL aliquot was obtained from each 
of three banked urine samples. Participant 
and blind quality control (QC) samples 
were sent on dry ice by overnight mail to the 
CDC laboratory in Atlanta, Georgia, where 
2,4-dichloro phenol, 2,5-dichloro phenol, 
butyl paraben, methyl paraben, propyl 
paraben, benzophenone-3, BPA, and triclosan 
were measured using previously published 
laboratory and QC methods (Ye et al. 2005, 
2006). The limits of detection (LODs) were 
0.2 μg/L (2,4-dichloro phenol, 2,5-dichloro-
phenol, butyl paraben, propyl paraben), 
0.4 μg/L (benzophenone-3, BPA), 1.0 μg/L 
(methyl paraben), and 2.3 μg/L (triclosan). 
Urine samples for each three-sample set were 
analyzed in the same batch to minimize the 
impact of interbatch variability. Results from 
a blind QC pool indicated excellent reliability 
for most analytes, with interbatch coefficients 
of variation (CVs) < 0.10; reliability was 
lower for BPA [CV = 0.18, geometric mean 
(GM) = 1.8 μg/L], triclosan (CV = 0.22, 
GM = 5.9 μg/L),  and 2,4-dichloro-
phenol (CV = 0.26, GM = 1.0 μg/L). As 
expected, CVs were higher for analytes at 
low concentrations.
Statistical analyses. We present analyte 
concentrations both creatinine-corrected (in 
micrograms per gram creatinine) and uncor-
rected (in micrograms per liter of urine) 
because age and chronic health conditions 
associated with age, such as chronic kidney 
disease, can influence crea tinine clearance and, 
thus also influence the impact of using cre-
atinine to adjust for urinary dilution (Waikar 
et al. 2010). Statistical analyses were performed 
only for analytes with detectable concentra-
tions in ≥ 50% of samples (2,4-dichloro-
phenol, 2,5-dichloro phenol, BPA, methyl 
paraben, propyl paraben) (Table 2). Samples 
with creatinine concentrations < 20 mg/dL 
(two men’s baseline samples and one woman’s 
second sample) or > 275 mg/dL (one woman’s 
baseline sample) were excluded from analysis. 
Statistical analyses were conducted separately 
for males and females.
Values below the LOD were replaced 
by the LOD divided by the square root of 2 
for all analyses (Hornung and Reed 1990). 
Because concentrations were log distributed, 
values were log-transformed for tests that 
required a normal distribution. GMs and 
95% confidence intervals (CIs) were calcu-
lated. The Satterthwaite t-test was used to 
investigate binary predictors of concentration. 
Dose–response relations were evaluated using 
least squares regression of log-transformed 
concentrations on continuous measures of 
age, education, income, and body mass index 
(BMI). We also used multi ple linear regression 
to simultaneously examine multi ple predictors 
Table 2. Urinary phenol concentrations in the SWHS and SMHS.a
Phenol
Baseline Sample 2 Sample 3
Percent > LODb GM (5th, 95th percentile) Percent > LODb GM (5th, 95th percentile) Percent > LODb GM (5th, 95th percentile)
Women
Uncorrected (μg/L)
2,4-Dichloro phenol 89.8 1.29 (< LOD, 19.4) 89.8 1.06 (< LOD, 33.0) 94.0 1.31 (< LOD, 7.40)
2,5-Dichloro phenol 100.0 32.1 (2.90, 655) 100.0 37.2 (4.20, 983) 98.0 30.7 (3.40, 368)
Benzophenone-3 28.6 NA (< LOD, 3.10) 38.8 NA (< LOD, 40.6) 40.0 NA (< LOD, 4.30)
BPA 65.3 0.622 (< LOD, 2.30) 65.3 0.661 (< LOD, 2.10) 80.0 0.888 (< LOD, 3.80)
Butyl paraben 22.5 NA (< LOD, 5.20) 30.6 NA (< LOD, 8.80) 44.0 NA (< LOD, 40.4)
Methyl paraben 98.0 21.1 (1.90, 151) 100.0 21.5 (2.20, 209) 96.0 28.8 (1.00, 289)
Propyl paraben 71.4 2.54 (< LOD, 50.6) 79.6 2.07 (< LOD, 90.0) 82.0 3.06 (< LOD, 103)
Triclosan 32.7 NA (< LOD, 112) 32.7 NA (< LOD, 36.7) 46.0 NA (< LOD, 232)
Creatinine- corrected (μg/g)
2,4-Dichloro phenol 89.8 1.93 (< LOD, 18.0) 89.8 1.76 (< LOD, 45.6) 94.0 1.88 (< LOD, 11.9)
2,5-Dichloro phenol 100.0 48.1 (4.00, 678) 100.0 61.6 (9.87, 1477) 98.0 44.1 (5.58, 689)
Benzophenone-3 28.6 NA (< LOD, 3.84) 38.8 NA (< LOD, 27.7) 40.0 NA (< LOD, 8.40)
BPA 65.3 0.931 (< LOD, 3.98) 65.3 1.10 (< LOD, 4.21) 80.0 1.27 (< LOD, 3.45)
Butyl paraben 22.5 NA (< LOD, 7.29) 30.6 NA (< LOD, 25.2) 44.0 NA (< LOD, 24.9)
Methyl paraben 98.0 31.6 (3.65, 258) 100.0 35.6 (3.15, 262) 96.0 41.3 (2.73, 355)
Propyl paraben 71.4 3.79 (< LOD, 137) 79.6 3.42 (< LOD, 100) 82.0 4.38 (< LOD, 101)
Triclosan 32.7 NA (< LOD, 134) 32.7 NA (< LOD, 77.8) 46.0 NA (< LOD, 244)
Men
Uncorrected (μg/L)
2,4-Dichloro phenol 87.5 1.12 (< LOD, 18.1) 90.0 1.06 (< LOD, 8.70) 96.0 1.50 (0.300, 16.7)
2,5-Dichloro phenol 100.0 37.5 (3.30, 730) 100.0 30.9 (6.70, 333) 100.0 47.5 (5.20, 855)
Benzophenone-3 25.0 NA (< LOD, 3.40) 30.0 NA (< LOD, 2.10) 26.0 NA (< LOD, 1.50)
BPA 75.0 0.683 (< LOD, 2.20) 74.0 0.774 (< LOD, 3.40) 86.0 0.794 (< LOD, 1.90)
Butyl paraben 14.6 NA (< LOD, 0.500) 22.0 NA (< LOD, 3.00) 20.0 NA (< LOD, 2.40)
Methyl paraben 97.9 9.31 (1.50, 94.3) 94.0 15.7 (< LOD, 119) 98.0 12.8 (1.20, 159)
Propyl paraben 54.2 0.450 (< LOD, 27.6) 70.0 1.06 (< LOD, 19.6) 64.0 0.843 (< LOD, 37.2)
Triclosan 27.1 NA (< LOD, 109) 24.0 NA (< LOD, 63.6) 24.0 NA (< LOD, 78.3)
Creatinine-corrected (μg/g)
2,4-Dichloro phenol 87.5 1.18 (< LOD, 20.7) 90.0 1.09 (< LOD, 13.2) 96.0 1.48 (0.300, 12.9)
2,5-Dichloro phenol 100.0 39.5 (8.41, 761) 100.0 31.9 (6.44, 526) 100.0 46.9 (7.65, 561)
Benzophenone-3 25.0 NA (< LOD, 2.44) 30.0 NA (< LOD, 2.70) 26.0 NA (< LOD, 1.78)
BPA 75.0 0.720 (< LOD, 1.60) 74.0 0.800 (< LOD, 3.42) 86.0 0.784 (< LOD, 1.67)
Butyl paraben 14.6 NA (< LOD, 0.450) 22.0 NA (< LOD, 3.78) 20.0 NA (< LOD, 1.66)
Methyl paraben 97.9 9.81 (1.90, 65.6) 94.0 16.2 (< LOD, 175) 98.0 12.6 (1.14, 149)
Propyl paraben 54.2 0.474 (< LOD, 18.7) 70.0 1.10 (< LOD, 17.3) 64.0 0.833 (< LOD, 40.3)
Triclosan 27.1 NA (< LOD, 97.0) 24.0 NA (< LOD, 64.8) 24.0 NA (< LOD, 46.8)
NA, not available; GM was not calculated if > 50% of samples were below LOD. Samples with creatinine < 20 or > 275 mg/dL were excluded. Baseline samples collected during 
1998–2002 for women and 2003–2004 for men; second samples collected during 2006; third samples collected during 2006–2007.
aNumber of samples: for women, nbaseline = 49, nsample 2 = 49, nsample 3 = 50; for men, nbaseline = 48, nsample 2 = 50, nsample 3 = 50. bLODs are 2,4-dichloro phenol, 0.2 μg/L; 2,5-dichloro phenol, 
0.2 μg/L; benzophenone-3, 0.4 μg/L; BPA, 0.4 μg/L; butyl paraben, 0.2 μg/L; methyl paraben, 1.0 μg/L; propyl paraben, 0.2 μg/L; triclosan, 2.3 μg/L.
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of log- transformed creatinine-corrected 
concentrations of individual phenols. To 
screen the large number of potential predictors 
and obtain parsimonious models, we included 
only predictors with p < 0.1 in univariate 
analy es for a given phenol and limited analyses 
to phenols with two or more such predictors. 
Concentrations were compared with those 
from the U.S. National Health and Nutrition 
Examination Surveys (NHANES), using the 
corresponding NHANES results nearest the 
sampling  window of the Shanghai samples.
Intraindividual variability of phenol 
concentrations over time was evaluated in 
two ways. For each analyte, intraclass corre-
lation coefficients (ICCs) and 95% CIs 
of log-transformed baseline, sample 2, and 
sample 3 values were estimated using mixed 
effects models with batch and participant 
included as random effects. The ICC was 
calculated as σB2/(σW2 + σB2) [between-
participant variance/(within-participant 
variance + between-participant variance)]. The 
association between continuous concentra-
tions at baseline and the average of samples 2 
and 3 was evaluated using the nonparametric 
Spearman’s rank correlation coefficient (SCC). 
The average of samples 2 and 3 was used for 
calculating the SCC because these samples 
were collected relatively close in time com-
pared with the time between samples 1 and 2, 
and their average was considered more likely 
to provide a better estimate of an individual’s 
usual exposure in this later period than either 
sample individually. Analyses were performed 
using SAS (version 9.2; SAS Institute Inc., 
Cary, NC, USA). Statistical significance was 
assessed at the 5% level.
Results
The study participants were similar to their 
respective parent cohorts (Cai et al. 2007; 
Zheng et al. 2005) across a range of demo-
graphic and lifestyle factors (Table 1). Mean 
age at enrollment was 50.5 years (women) and 
56.3 years (men). None of the women were 
pregnant at enrollment. A substantially higher 
proportion of men than women were current 
cigarette smokers. Usual source of drinking 
water, which was ascertained only for women, 
was tap water among 66% of participants.
Most participants had detectable base-
line urine concentrations of 2,4-dichloro-
phenol, 2,5-dichloro phenol, BPA, methyl 
paraben, and propyl paraben, ranging 
from 71.4% of women and 54.2% of men 
for propyl paraben to 100% of women 
and men for 2,5-dichloro phenol (Table 2). 
Benzophenone-3, butyl paraben, and triclosan 
were detected in < 50% of baseline samples 
for both sexes. The proportion of detectable 
concentrations remained similar or increased 
for all analytes between the baseline and 
third samples, although the second samples 
suggested possible non monotonicity for 
some analytes; the increases were appreciable 
for benzophenone-3, BPA, butyl paraben, 
propyl paraben, and triclosan in at least one 
sex. Benzophenone-3, butyl paraben, propyl 
paraben, and triclosan were consistently 
detected more often among women, whereas 
BPA was consistently detected more frequently 
among men. As expected, creatinine concen-
trations were appreciably higher among men 
(data not shown).
Although trends were not monotonic for 
all analytes, mean creatinine-corrected concen-
trations of BPA, methyl paraben, and propyl 
paraben increased modestly between the base-
line and third samples for both sexes, whereas 
2,4-dichloro phenol and 2,5-dichloro phenol 
concentrations increased only among men and 
were similar or decreased slightly among women 
(Table 2). The magnitude of increase differed 
by analyte and sex: BPA increased 36.4% 
among women and 8.9% among men, methyl 
paraben increased 28.4–30.7% in women and 
men; propyl paraben, with the greatest relative 
difference between the sexes, increased 15.6% 
among women and 75.7% among men. The 
pattern was similar for  creatinine-corrected and 
uncorrected concentrations.
Creatinine-corrected concentrations of 
2,4-dichloro phenol and 2,5-dichloro phenol 
were higher in the baseline samples compared 
with the 2003–2004 NHANES, whereas 
the opposite was seen for BPA, methyl para-
ben, and propyl paraben (see Supplemental 
Material, Table S1). This pattern was consis-
tent for both sexes and remained unchanged 
for the third sample compared with the 
2007–2008 NHANES. There was a general 
pattern of increasing concentrations over time 
in the Shanghai samples, whereas the pattern 
was more mixed in NHANES. The uncor-
rected measurements showed similar patterns 
(see Supplemental Material, Table S2).
Table 3 shows GMs of creatinine- 
corrected concentrations at baseline, strati-
fied by selected factors. GMs of methyl 
paraben and propyl paraben were significantly 
higher among women. The GM of BPA also 
appeared higher among women (p = 0.06), 
despite the somewhat higher prevalence of 
detection and uncorrected concentrations of 
BPA among men (see Supplemental Material, 
Table S3). Income showed significant dose–
response trends with 2,4-dichloro phenol, 
2,5-dichloro phenol, and BPA concentra-
tions, although no associations were observed 
in dichotomous analyses. Propyl paraben 
GMs were significantly lower among current 
smokers than among former or never-smokers. 
Women who drank primarily bottled water 
had significantly higher urinary concentrations 
of 2,4-dichloro phenol and 2,5-dichloro phenol 
and appeared to have higher concentrations of 
BPA (p = 0.08) compared with women who 
drank primarily tap water. Use of medication 
within the previous 24 hr was associated 
with significantly higher urinary concentra-
tions of propyl paraben. BPA concentration 
was significantly higher in urine collected in 
the afternoon/evening compared with urine 
collected in the morning.
Creatinine-corrected concentrations in 
the third sample were also significantly higher 
among women for BPA, methyl paraben, and 
propyl paraben (Table 4). Propyl paraben 
concentrations appeared to be higher among 
participants ≤ 50 years of age compared with 
older participants (p = 0.06). Income showed 
positive associations with 2,4-dichloro phenol, 
2,5-dichloro phenol, and BPA concentrations 
in dichotomous analyses (p < 0.06) and sig-
nificant dose–response trends. Concentrations 
of methyl paraben were lower among cur-
rent smokers compared with former or never-
smokers. Similar patterns were observed for 
uncorrected concentrations (see Supplemental 
Material, Table S4).
In multivariate models for individual 
analytes, the above predictors of creatinine-
corrected concentrations generally remained 
significant, except for age, in years, in rela-
tion to methyl paraben in the first sample and 
> 50 years of age in relation to propyl paraben 
in the third sample (Table 5).
Temporal reproducibility among the 
three samples per participant tended to be 
higher for men than for women (Table 6). 
We observed moderately high ICCs and 
SCCs among men for 2,4-dichloro phenol 
and 2,5-dichloro phenol, with values ranging 
from 0.54 to 0.60 (ICC) and 0.43 to 0.56 
(SCC). The corresponding measures among 
women were 0.29–0.39 and 0.12–0.35, 
respectively, indicating poor reproduc-
ibility. These measures were poor to fair 
for the other analytes. The ICCs and SCCs 
for 2,4-dichloro phenol and 2,5-dichloro-
phenol increased for both men and women 
when analyses were restricted to samples 
collected in the morning, whereas patterns 
for other analytes were inconsistent (see 
Supplemental Material, Table S5); however, 
CIs were very wide.
Discussion
These results suggest that, in this population 
of Shanghai adults, a single spot urine sample 
should allow a moderately reliable ranking 
of individuals’ exposure to the precursors of 
2,4-dichloro phenol and 2,5-dichloro phenol 
relative to other participants among men and, 
under certain circumstances, among women. 
It is unlikely to be adequate for ranking of 
exposure to other phenols for either sex. We 
detected 2,4-dichloro phenol, 2,5-dichloro-
phenol, BPA, methyl paraben, and propyl 
paraben among most participants in the pres-
ent study. Concentrations of several of the 
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phenols, including methyl paraben, propyl 
paraben, BPA, and 2,4-dichloro phenol, were 
higher among women. Mean creatinine-
corrected concentrations of BPA, methyl 
paraben, and propyl paraben increased over 
time for both sexes, whereas 2,4-dichloro-
phenol and 2,5-dichloro phenol concentra-
tions increased only among men. Lifestyle 
factors related to urinary concentrations of 
one or more of these chemicals included 
smoking, consumption of bottled water, and 
income, although the relationships appeared 
to vary over the study period.
The mean BPA urinary concentrations 
observed in the present study are comparable 
to those reported in two Chinese studies 
among similarly aged persons during a simi-
lar time period (Ning et al. 2011; Zhang 
et al. 2011), although they are higher than 
those observed among persons > 40 years of 
age in a study of non occupationally exposed 
Chinese factory workers and their families 
(He et al. 2009). Studies in South Korea have 
reported urinary concentrations of BPA that 
are 2–3 times higher than those observed in 
the present study and in other Chinese studies 
(Kim et al. 2011; Zhang et al. 2011). Reasons 
for the observed differences are unclear.
The sex differences observed in the 
absolute concentrations and in the agreement 
over time in relative concentrations of some 
of these analytes are not surprising, given 
that several of the compounds, including the 
parabens, are present in cosmetics and other 
personal care products used primarily by 
women. It is noteworthy that most of these 
differences persisted across the time period of 
the present study.
The evidence for sex differences in 
body burdens of BPA is mixed, with some 
Asian studies reporting higher concentra-
tions among men (He et al. 2009; Ning 
et al. 2011) and others reporting no differ-
ence (Kim et al. 2011; Li et al. 2013; Zhang 
et al. 2011). We found higher concentrations 
Table 3. GMs (95% CIs) of creatinine-corrected baseline sample urinary phenol concentrations (μg/g) by selected characteristics.
Characteristic n 2,4-Dichloro phenol 2,5-Dichloro phenol BPA Methyl paraben Propyl paraben
Sex
Female 49 1.93 (1.30, 2.88) 48.1 (30.4, 76.0) 0.931 (0.754, 1.15) 31.6 (21.1, 47.2) 3.79 (1.82, 7.92)
Male 48 1.18 (0.741, 1.87) 39.5 (25.3, 61.6) 0.720 (0.608, 0.851) 9.81 (7.02, 13.7) 0.474 (0.281, 0.797)
p-Valuea 0.10 0.54 0.06 < 0.001 < 0.001
Age (years)
≤ 50 42 1.69 (1.04, 2.75) 57.4 (35.1, 94.0) 0.811 (0.636, 1.04) 19.6 (12.9, 29.9) 1.50 (0.726, 3.09)
> 50 55 1.39 (0.937, 2.06) 35.3 (23.4, 53.4) 0.826 (0.706, 0.966) 16.4 (11.1, 24.2) 1.25 (0.630, 2.50)
p-Valuea 0.53 0.13 0.90 0.52 0.72
Trend p-valueb 0.77 0.48 0.91 0.04 0.31
Education
≤ Middle school 52 1.50 (1.00, 2.23) 41.3 (27.54, 61.8) 0.813 (0.677, 0.977) 15.3 (10.3, 22.8) 1.34 (0.687, 2.62)
> Middle school 45 1.53 (0.948, 2.47) 46.4 (27.9, 77.3) 0.826 (0.671, 1.02) 20.9 (13.8, 31.6) 1.37 (0.644, 2.91)
p-Valuea 0.94 0.71 0.91 0.28 0.97
Trend p-valueb 0.45 0.21 0.71 0.22 0.76
Incomec
Low 62 1.33 (0.912, 1.95) 40.1 (27.4, 58.7) 0.768 (0.655, 0.902) 14.9 (10.4, 21.3) 1.08 (0.581, 2.02)
High 35 1.89 (1.13, 3.17) 50.6 (28.5, 89.9) 0.918 (0.714, 1.18) 24.0 (15.0, 38.2) 2.02 (0.881, 4.61)
p-Valuea 0.28 0.50 0.23 0.11 0.23
Trend p-valueb 0.02 0.02 0.05 0.19 0.22
Baseline BMI (kg/m2)
< 25 59 1.58 (1.06, 2.37) 45.7 (30.4, 68.7) 0.871 (0.726, 1.04) 17.0 (11.6, 24.8) 1.15 (0.610, 2.18)
≥ 25 38 1.41 (0.871, 2.27) 40.5 (24.1, 68.1) 0.746 (0.607, 0.916) 18.9 (12.1, 29.4) 1.74 (0.779, 3.88)
p-Valuea 0.70 0.72 0.26 0.71 0.42
Trend p-valueb 0.25 0.36 0.74 0.73 0.95
Smokingd
Former/never 19 1.22 (0.516, 2.89) 37.5 (15.7, 89.7) 0.709 (0.557, 0.904) 13.8 (7.43, 25.8) 0.951 (0.364, 2.49)
Current 29 1.15 (0.654, 2.01) 40.8 (24.3, 68.4) 0.726 (0.571, 0.924) 7.83 (5.33, 11.5) 0.300 (0.168, 0.534)
p-Valuea 0.90 0.86 0.89 0.11 0.04
≥ 13 Cigarettes/day among smokersd
No 12 0.702 (0.259, 1.91) 29.2 (13.4, 63.9) 0.801 (0.514, 1.25) 7.33 (3.46, 15.6) 0.350 (0.130, 0.944)
Yes 17 1.62 (0.811, 3.24) 51.6 (24.7, 108.) 0.678 (0.499, 0.921) 8.19 (5.14, 13.1) 0.269 (0.123, 0.588)
p-Valuea 0.15 0.26 0.51 0.79 0.66
Consume bottled watere
No 32 1.32 (0.844, 2.05) 30.7 (18.4, 51.2) 0.792 (0.661, 0.951) 35.7 (20.8, 61.4) 4.55 (1.73, 12.0)
Yes 17 4.00 (1.95, 8.21) 112.0 (48.6, 256.) 1.26 (0.758, 2.09) 25.0 (13.6, 46.0) 2.70 (0.799, 9.11)
p-Valuea 0.01 0.01 0.08 0.37 0.49
Postmenopausale
No 25 2.09 (1.16, 3.75) 52.0 (26.1, 104.) 0.980 (0.686, 1.40) 33.8 (18.9, 60.5) 5.61 (2.27, 13.9)
Yes 23 1.68 (0.931, 3.03) 41.1 (21.1, 79.8) 0.888 (0.685, 1.15) 27.5 (14.9, 50.5) 2.16 (0.629, 7.44)
p-Valuea 0.59 0.61 0.65 0.61 0.21
Took medicine within previous 24 hr
No 39 1.43 (0.902, 2.27) 41.9 (25.9, 67.8) 0.841 (0.677, 1.05) 14.8 (10.4, 21.0) 0.649 (0.352, 1.20)
Yes 58 1.57 (1.04, 2.37) 44.8 (29.2, 68.6) 0.805 (0.674, 0.962) 20.0 (13.2, 30.3) 2.22 (1.11, 4.46)
p-Valuea 0.77 0.83 0.75 0.27 0.009
Time of day of urine collection
Morning 31 1.52 (0.889, 2.59) 48.4 (29.6, 79.2) 0.639 (0.508, 0.804) 16.3 (9.52, 27.8) 0.930 (0.371, 2.33)
Afternoon/evening 66 1.51 (1.04, 2.20) 41.5 (27.6, 62.4) 0.921 (0.782, 1.08) 18.4 (13.1, 25.9) 1.62 (0.894, 2.92)
p-Valuea 0.99 0.63 0.01 0.69 0.31
Samples with creatinine < 20 or > 275 mg/dL were excluded. Benzophenone-3, butyl paraben, and triclosan were excluded because > 50% of samples were below LOD.
ap-Value for Satterthwaite t-test. bp-Value for continuous measure in linear regression models testing dose response (age, education, income, and BMI only). cHigh income was 
defined as ≥ 20,000 yuan/year for females and ≥ 12,000 yuan/year for males. dMales only. eFemales only.
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among women, which is consistent with 
NHANES (Calafat et al. 2008). The reason 
for this discrepancy is unclear. The associa-
tion between smoking and BPA concentra-
tion is also uncertain, with one Chinese 
study reporting a positive association (He 
et al. 2009), but no association observed in 
other Asian studies (Kim et al. 2011; Ning 
et al. 2011), including the present study, nor 
in the United States (Calafat et al. 2008). 
The increased concentration of BPA that 
we observed in relation to consumption of 
bottled water, which approached statistical 
significance (p = 0.08), is consistent with 
the one other Chinese study that examined 
this (Li et al. 2013). The higher concentra-
tion of propyl paraben among persons who 
took medication within the previous 24 hr 
is intriguing, given that propyl paraben is a 
widely used preservative in pharmaceutical 
products (Soni et al. 2005). We have not seen 
this association reported in previous Chinese 
studies and we lacked the data necessary to 
investigate it further, including formulation 
and brand/source of the medications.
Data on triclosan exposure in Asia are 
limited. Studies among Chinese children 
and young adults (Li et al. 2013) and Korean 
adults (Kim et al. 2011) reported GMs of 
3.77 μg/L and 1.68 μg/L, respectively. Most 
samples in our study were below the LOD 
of 2.3 μg/L.
Most studies of temporal variability of 
urinary BPA concentrations have been of 
short duration and have reported similarly 
low ICCs of around 0.1–0.2 (Braun et al. 
2011, 2012; Meeker et al. 2011; Ye et al. 
2011), although one study of children 
reported a somewhat higher ICC of 0.35 
(Teitelbaum et al. 2008). A study of banked 
specimens collected from premenopausal 
women in the 1980s reported an SCC of 
0.5 between samples collected 2 weeks apart, 
but 0.3 for samples collected 4 weeks apart 
(Nepomnaschy et al. 2009). Although one 
study reported moderate sensitivity of a single 
urine sample to predict mean BPA concen-
tration tertiles over approximately 5 months 
(Mahalingaiah et al. 2008), most evidence 
suggests that a single measurement is unlikely 
to accurately reflect long-term exposure to 
BPA. In addition, Meeker et al (2011) 
reported SCCs and ICCs for creatinine- 
corrected concentrations of methyl paraben 
and propyl paraben among men that were 
comparable to those in the present study, 
although Smith et al (2012) observed some-
what higher ICCs for these chemicals. All 
but two of these studies (Nepomnaschy et al. 
2009; Ye et al. 2011) used spot samples.
The degree to which a single urine sample 
reflects an individual’s long-term concen-
trations of these chemicals depends on the 
within-person variability of these concentra-
tions over time. Greater within-person vari-
ability will result in increased measurement 
Table 4. GMs (95% CIs) of creatinine-corrected third sample urinary phenol concentrations (μg/g) by selected characteristics.
Characteristic n 2,4-Dichloro phenol 2,5-Dichloro phenol BPA Methyl paraben Propyl paraben
Sex
Female 50 1.88 (1.34, 2.63) 44.1 (27.7, 70.2) 1.27 (1.05, 1.54) 41.3 (27.6, 61.7) 4.38 (2.25, 8.55)
Male 50 1.48 (1.05, 2.09) 46.9 (31.6, 69.7) 0.784 (0.673, 0.914) 12.6 (8.24, 19.3) 0.833 (0.450, 1.54)
p-Valuea 0.32 0.84 < 0.001 < 0.001 < 0.001
Age (years)
≤ 50 44 1.83 (1.23, 2.71) 49.9 (30.2, 82.6) 1.00 (0.830, 1.20) 26.7 (15.6, 45.8) 3.20 (1.49, 6.86)
> 50 56 1.55 (1.15, 2.10) 42.2 (29.0, 61.5) 1.00 (0.830, 1.20) 20.2 (13.9, 29.3) 1.28 (0.698, 2.33)
p-Valuea 0.52 0.59 1.00 0.39 0.06
Trend p-valueb 0.59 0.77 0.59 0.44 0.34
Education
≤ Middle school 54 1.64 (1.17, 2.28) 45.5 (30.1, 68.8) 1.02 (0.843, 1.23) 23.2 (15.2, 35.3) 2.06 (1.07, 3.98)
> Middle school 46 1.71 (1.20, 2.43) 45.4 (28.9, 71.4) 0.980 (0.815, 1.18) 22.4 (13.9, 36.2) 1.75 (0.857, 3.57)
p-Valuea 0.86 0.99 0.78 0.92 0.74
Trend p-valueb 0.68 0.53 0.53 0.84 0.87
Incomec
Low 65 1.43 (1.04, 1.97) 37.4 (25.0, 55.8) 0.908 (0.775, 1.06) 20.6 (13.6, 31.3) 1.48 (0.802, 2.72)
High 35 2.23 (1.60, 3.09) 65.5 (43.0, 99.7) 1.20 (0.955, 1.50) 27.6 (17.5, 43.6) 3.08 (1.43, 6.63)
p-Valuea 0.05 0.06 0.05 0.34 0.13
Trend p-valueb 0.03 0.04 0.03 0.21 0.10
BMI
< 25 kg/m2 56 1.61 (1.18, 2.19) 42.3 (28.3, 63.2) 0.997 (0.854, 1.16) 25.1 (16.2, 38.9) 2.29 (1.17, 4.47)
≥ 25 kg/m2 41 1.73 (1.14, 2.62) 50.8 (30.8, 83.9) 1.01 (0.798, 1.28) 20.4 (12.6, 32.8) 1.54 (0.747, 3.18)
p-Valuea 0.78 0.57 0.93 0.52 0.42
Trend p-valueb 0.91 0.98 0.90 0.53 0.78
Smokingd
Former/never 19 1.70 (0.852, 3.37) 53.3 (27.1, 105.) 0.764 (0.584, 1.00) 24.6 (14.0, 43.4) 1.60 (0.509, 5.01)
Current 31 1.36 (0.912, 2.03) 43.4 (26.0, 72.4) 0.797 (0.655, 0.970) 8.38 (4.75, 14.8) 0.559 (0.272, 1.15)
p-Valuea 0.57 0.62 0.79 0.008 0.12
≥13 Cigarettes/day among smokersd
No 12 1.38 (0.648, 2.93) 49.9 (20.4, 122.) 0.831 (0.632, 1.09) 7.17 (2.96, 17.4) 0.513 (0.171, 1.54)
Yes 19 1.35 (0.811, 2.25) 39.7 (20.0, 78.8) 0.777 (0.582, 1.04) 9.24 (4.15, 20.6) 0.590 (0.210, 1.66)
p-Valuea 0.96 0.66 0.72 0.65 0.84
Consume bottled watere
No 33 1.87 (1.21, 2.88) 42.6 (22.7, 79.6) 1.26 (0.985, 1.60) 33.3 (19.7, 56.1) 3.90 (1.67, 9.08)
Yes 17 1.91 (1.07, 3.41) 47.1 (23.0, 96.6) 1.31 (0.926, 1.86) 62.7 (33.3, 118.) 5.51 (1.66, 18.3)
p-Valuea 0.95 0.82 0.83 0.12 0.63
Postmenopausale
No 26 2.24 (1.39, 3.60) 47.8 (23.2, 98.3) 1.22 (0.972, 1.54) 50.7 (29.9, 86.0) 7.42 (2.97, 18.5)
Yes 23 1.50 (0.898, 2.51) 37.5 (19.8, 71.0) 1.27 (0.912, 1.77) 34.4 (17.7, 67.0) 2.57 (0.909, 7.24)
p-Valuea 0.25 0.61 0.86 0.35 0.12
Samples with creatinine < 20 or > 275 mg/dL were excluded.
ap-Value for Satterthwaite t-test. bp-Value for continuous measure in linear regression models testing dose response (age, education, income, and BMI only). cHigh income was 
defined as ≥ 20,000 yuan/year for females and ≥ 12,000 yuan/year for males. dMales only. eFemales only.
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error of a single measurement and, conse-
quently, greater attenuation of observed asso-
ciations (e.g., relative risks). Understanding 
how well a single measurement reflects longer-
term concentrations is essential for conduct-
ing and interpreting epidemiologic studies of 
these associations.
Study strengths include availability of 
serial urine samples collected over several years, 
allowing investigation of the reliability of expo-
sure assessment over a substantially longer 
period than previously examined. We were 
also able to analyze this reliability for several 
phenols in addition to BPA and parabens. Our 
samples were analyzed in the same laboratory 
and with the same methods as NHANES sam-
ples, allowing direct comparison of measured 
concentrations between the United States and 
China. Last, we studied general population 
cohorts that were generally representative of 
middle-aged and older persons in Shanghai.
Limitations of the present study include 
its relatively small sample size, especially when 
stratified by sex. Nonetheless, we were able 
to identify a number of potential predictors 
of exposure in this population. Additional 
samples collected during follow-up would have 
allowed better estimation of exposure to these 
chemicals over time, although few long-term 
prospective cohorts have more than a base-
line spot urine sample. Information on bottled 
water consumption, which was a potential pre-
dictor of exposure to several of the chemicals, 
was available only for women. In addition, 
we lacked detailed information on medica-
tions used. The small number of participants 
who provided second or third urine samples 
in the afternoon/evening limited our ability 
to account for timing of collection when esti-
mating reliability. Last, some observed associa-
tions may be due to chance because of the large 
number of comparisons performed.
Conclusions
Exposure to the precursors of 2,4-dichloro-
phenol and 2,5-dichloro phenol and to BPA, 
methyl paraben, and propyl paraben is wide-
spread among Chinese adults > 40 years of 
age, with a smaller, but substantial and grow-
ing, proportion exposed to benzophenone-3, 
butyl paraben, and triclosan. Chinese women 
appear to be more exposed to these chemicals 
than do men, which may be due to differ-
ences in the use of personal care products 
such as cosmetics, antimicrobial soaps, and 
moisturizing lotions. Consumption of bot-
tled water or related lifestyle factors may also 
be associated with greater exposure to sev-
eral of these chemicals (or their precursors), 
including 2,4-dichloro phenol, 2,5-dichloro-
phenol, and BPA. The Chinese profile differs 
from that of the United States, with higher 
concentrations of 2,4-dichloro phenol and 
2,5-dichloro phenol, but lower concentra-
tions of BPA, methyl paraben, and propyl 
paraben. Lastly, our results suggest that, in 
similar populations, a single spot urine sam-
ple may be adequate for ranking exposure 
to the precursors of 2,4-dichloro phenol and 
2,5-dichloro phenol among men and, under 
certain circumstances, among women, and 
that multi ple measurements are needed to 
capture the exposure variability of the other 
chemicals. These findings require replication 
in other age and demographic groups but 
provide valuable information for future study 
of these chemicals in Chinese populations.
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Table 5. Univariate and multi ple linear regression coefficients (95% CI) for creatinine-corrected urinary 
phenol concentrations and selected participant/specimen characteristics, by specimen collection.
Phenol and characteristic
Regression coefficient
Univariate models Multivariate models
Baseline sample
BPA
Male (vs. female) –0.26 (–0.52, 0.01) –0.12 (–0.40, 0.16)
Annual income (per 1,000 yuan, continuous) 0.21 (0.05, 0.36) 0.17 (0.01, 0.34)
Urine collected in afternoon/evening (vs. morning) 0.36 (0.09, 0.64) 0.35 (0.08, 0.62)
Methyl paraben
Male (vs. female) –1.17 (–1.68, –0.66) –1.09 (–1.63, –0.55)
Age (per year, continuous) –0.03 (–0.06, 0.00) –0.01 (–0.04, 0.02)
Propyl paraben
Male (vs. female) –2.08 (–2.96, –1.20) –2.15 (–3.00, –1.31)
Took medicine in previous 24 hr (vs. no medicine in previous 24 hr) 1.23 (0.26, 2.19) 1.35 (0.49, 2.21)
Third sample
BPA
Male (vs. female) –0.48 (–0.72, –0.25) –0.37 (–0.63, –0.12)
Annual income (per 1,000 yuan, continuous) 0.26 (0.11, 0.41) 0.17 (0.02, 0.33)
Propyl paraben
Male (vs. female) –1.66 (–2.55, –0.77) –1.54 (–2.44, –0.64)
Age > 50 years (vs. ≤ 50 years) –0.92 (–1.85, 0.01) –0.61 (–1.52, 0.30)
Samples with creatinine < 20 or > 275 mg/dL were excluded. Multiple linear regression models for each phenol include 
all predictors that were statistically significant at p < 0.1 in univariate analyses. Certain models could not be tested 
because a given predictor was defined for only a subgroup (e.g., bottled water consumption) or because of collinearity 
(e.g., sex and cigarette smoking).
Table 6. Measures of reproducibility for urinary phenol concentrations.
Phenol
Females Males
ICC (95% CI)a Correlationb ICC (95% CI)a Correlationb
Uncorrected (μg/L)
2,4-Dichloro phenol 0.35 (0.21, 0.51) 0.22 0.55 (0.43, 0.67) 0.55
2,5-Dichloro phenol 0.29 (0.16, 0.47) 0.12 0.59 (0.47, 0.70) 0.52
BPA 0.07 (0.01, 0.50) 0.13 0.32 (0.19, 0.49) 0.31
Methyl paraben 0.24 (0.12, 0.43) 0.44 0.22 (0.10, 0.41) 0.24
Propyl paraben 0.31 (0.17, 0.48) 0.41 0.29 (0.16, 0.47) 0.36
Creatinine-corrected (μg/g)
2,4-Dichloro phenol 0.39 (0.26, 0.54) 0.35 0.54 (0.41, 0.66) 0.43
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